Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Sign up now for inspiring and thought-provoking media delivered straight to your inbox.
Support Provided By

57:46
April 18, 2025 - PBS News Hour full episode

57:46
April 17, 2025 - PBS News Hour full episode

57:46
April 16, 2025 - PBS News Hour full episode

57:46
April 15, 2025 - PBS News Hour full episode

57:46
April 14, 2025 - PBS News Hour full episode

26:44
April 13, 2025 - PBS News Weekend full episode

26:45
April 5, 2025 - PBS News Weekend full episode

26:44
January 12, 2025 - PBS News Weekend full episode

26:45
January 11, 2025 - PBS News Weekend full episode

57:46
Israel's Prime Minister says the intense phase of the war in Gaza will end soon as Israel and the U.S. argue over weapons deliveries.

57:46
After Claudia Sheinbaum becomes the first woman to win Mexico's presidential election, a look at what that means for U.S. relations.

26:44
"PBS NewsHour" asks NATO’s Secretary General if the delayed U.S. aid to Ukraine is too late to make a difference.